Search results
Jump to navigation
Jump to search
Page title matches
- ...tructure.jpg|right|thumb|150px|{{|{{Mevalonate structure.jpg/credit}}<br/>|Mevalonate.]] ...or|HMG-CoA reductase inhibitor]]s that work by inhibiting the synthesis of mevalonate from the reduction of [[3-hydroxy-3-methyl-glutaryl CoA]] (HMG-CoA).720 bytes (97 words) - 08:34, 8 June 2009
- 100 bytes (12 words) - 10:57, 6 July 2008
- 12 bytes (1 word) - 13:58, 24 January 2008
- Auto-populated based on [[Special:WhatLinksHere/Mevalonate]]. Needs checking by a human.592 bytes (72 words) - 18:29, 11 January 2010
Page text matches
- ...tructure.jpg|right|thumb|150px|{{|{{Mevalonate structure.jpg/credit}}<br/>|Mevalonate.]] ...or|HMG-CoA reductase inhibitor]]s that work by inhibiting the synthesis of mevalonate from the reduction of [[3-hydroxy-3-methyl-glutaryl CoA]] (HMG-CoA).720 bytes (97 words) - 08:34, 8 June 2009
- {{Image|Mevalonate synthesis.jpg|right|250px|Biosynthesis of mevalonate from HMG CoA.}} ...tase inhibitor|HMG-CoA reductase inhibitor]]s which block the synthesis of mevalonate from HMG CoA.508 bytes (67 words) - 06:05, 8 June 2009
- A chemical precursor of [[mevalonate]] and, therefore, [[cholesterol]].107 bytes (11 words) - 14:03, 7 July 2008
- {{r|mevalonate}}337 bytes (35 words) - 13:08, 8 July 2008
- {{r|mevalonate}}352 bytes (36 words) - 13:07, 8 July 2008
- {{r|mevalonate}}352 bytes (36 words) - 13:08, 8 July 2008
- {{r|mevalonate}}352 bytes (36 words) - 13:09, 8 July 2008
- {{r|mevalonate}}352 bytes (36 words) - 13:09, 8 July 2008
- {{r|mevalonate}}352 bytes (36 words) - 13:10, 8 July 2008
- {{r|mevalonate}}352 bytes (36 words) - 13:10, 8 July 2008
- {{r|mevalonate}}352 bytes (36 words) - 13:06, 8 July 2008
- ...uctase inhibitor|HMG-CoA reductase]], which diminishes the production of [[mevalonate]], a key precursor of [[cholesterol]]. It is a class i statin and it simil491 bytes (62 words) - 08:34, 8 June 2009
- ...the conversion of HMG-CoA to [[mevalonate]]. The conversion of HMG-CoA to mevalonate is an early step in the biosynthetic pathway of cholesterol. It was the fi2 KB (215 words) - 08:31, 8 June 2009
- Auto-populated based on [[Special:WhatLinksHere/Mevalonate]]. Needs checking by a human.592 bytes (72 words) - 18:29, 11 January 2010
- {{r|Mevalonate}}682 bytes (81 words) - 07:34, 8 January 2010
- {{r|Mevalonate}}1 KB (153 words) - 17:20, 11 January 2010
- ...simvastatin]]. Suppression of HMG-CoA reductase decreases production of [[mevalonate]], a key chemical precursor of [[cholesterol]].1 KB (185 words) - 08:03, 8 June 2009
- ...-CoA reductase inhibitor]] which diminishes the conversion of HMG-CoA to [[mevalonate]], a key chemical precursor of [[cholesterol]].2 KB (264 words) - 06:31, 8 June 2009
- ...G-CoA reductase inhibitor]] that decreases the conversion of HMG-CoA to [[mevalonate]], a key chemical precursor of [[cholesterol]]. It is related to other typ2 KB (265 words) - 14:07, 2 February 2023
- ...inhibitor|HMG-CoA reductase inhibitor]] that decreases the synthesis of [[mevalonate]], a key chemical precursor of [[cholesterol]]. Although the structure is2 KB (287 words) - 06:18, 8 June 2009